CSIMarket


Bioadaptives Inc   (BDPT)
Other Ticker:  
 


 

Bioadaptives Inc

BDPT's Financial Statements and Analysis



Bioadaptives Inc reported break-even for the third quarter of 2023 compare to earnings per share of $0.00 recorded in the same quarter a year ago an improvement compare to $0.00 realized in previous quarter.


third quarter of 2023
Earnings Per Share Revenues
$ 0 $  0 Mill
Unch.     Unch.     +368.95 %



Bioadaptives Inc 's Revenue rose by 368.95 % in third quarter of 2023 (Sep 30 2023) year on year, to $0 million and advanced by 569.05 % sequentially.


Bioadaptives Inc is Expected to report next financial results on March 30, 2024.

More on BDPT's Income Statement



Bioadaptives Inc 's in thethird quarter of 2023 recorded net loss of $-0.013 million, an improvement compare to net loss of $-0.276 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-0.144 million realized in previous quarter.

More on BDPT's Growth

Bioadaptives Inc Inventories
Inventories declined by -9.38 % to $0.01 million from III. Quarter a year ago, sequentially inventories rose by 11.76 %. BDPT's Cash flow In the third quarter of 2023 company's net cash flow was $0 million


Bioadaptives Inc





Company issued 288.26 million shares or 65.26 % in Sep 30 2023.


More on BDPT's Dividends

 Market Capitalization (Millions) 0
 Shares Outstanding (Millions) 730
 Total Debt (Millions $) 0
 Revenue (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Bioadaptives Inc





Company issued 288.26 million shares or 65.26 % in Sep 30 2023.


More on BDPT's Balance Sheets

 Market Capitalization (Millions) 0
 Shares Outstanding (Millions) 730
 Total Debt (Millions $) 0
 Revenue (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Bioadaptives Inc Earnings

Bioadaptives Inc Breakthrough: How This Pharmacy Industry Leader Achieved Remarkable Top-Line Growth in Recent Fiscal Period



Bioadaptives Inc, a leading ...

Major Pharmaceutical Preparations Company Surges with a Whopping 128.57% Year-to-Date Gain and 14.29% Increase in Stock Price in Just 5 Days!

Bioadaptives Inc, a Major Pharmaceutical Preparations company, has seen a significant increase in its stock price over the past 5 trading days. The stock gained 14.29% during this period, which has further extended its ye...

Bioadaptives Inc Experiences Dramatic Decline in Revenue during Fiscal Interval Ending March 31, 2023

The stock market is buzzing with excitement as we look forward to the next financial results of Bioadaptives Inc, set to be reported on August 11, 2023. The first quarter of 2023 earnings season saw some impressive results, with BDPT reaching an astounding $0.00 per share, compared to $0.00 per share last year. In addition, the company's revenue faded to $0.00 million from $0.01 million in the same reporting period a year ago and sequentially from $0.00 million.
Bioadaptives Inc continued to perform well, reporting a net deficit of just $-0.287 million, instead of the $-0.367 million deficit in the same reporting period a year ago. This is a testament to the hard work and dedication of the entire team at...


Date modified: 2023-11-14T17:45:54+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com